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ABSTRACT 
 
In this project, we developed a Western blotting procedure to semi-quantitate levels of 11β - 
HSD1 and 11β-HSD2 in whole cell extracts.  Then, we applied this technique to analyze the 
effect of reduced maternal aldosterone levels on the expression of 11β-HSD1 and 11β-HSD2 
isoenzymes in the placental tissue in both normal and hypertensive rats.  These enzymes control 
levels of glucocorticoids which compete for aldosterone’s mineralocorticoid receptor. 
Overstimulation of this receptor results in hypertension.   If aldosterone levels decrease, levels of 
the enzymes controlling active glucocorticoid concentrations might change to compensate for the 
lowered aldosterone levels.   Decreased placental 11β-HSD2 expression could affect 
hypertension in the offspring.  The Western blotting procedure was optimized for the detection 
of the two isoenzymes in their dimeric forms. The use of multiple protein levels on the blot was 
useful to obtain a more reliable semi-quantitation.   Because of the presence of multiple bands, it 
was impossible to use an internal beta actin standard to normalize the data from one blot to 
another.   This along with the low expression levels and uneven blot backgrounds made it 
difficult to obtain enough data on the expression of the two isoenzymes.  Very limited data do 
not support differences in the placental expression of the two isoenzymes when maternal 
aldosterone levels are lowered. 
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INTRODUCTION 
 
The enzymes 11-β HSD1 and HSD2 are very important in steroid hormone metabolism. 
 
The roles of 11β-HSD1 and 11β-HSD2 are to interconvert cortisol and the inactive 
glucocorticoid, cortisone in humans.  They also convert corticosterone and 11- 
dehydrocorticosterone in rodents [Gomez-Sanchez, 2003].   There are two different forms of the 
enzyme 11β-HSD. The first one, 11β− HSD1 acts as an oxidoreductase to form the active 
glucocorticoid cortisol or corticosterone in rats. The second isoform is 11β- HSD2 which 
produces inactive 11-keto metabolites.  The reactions for the isoenzymes are given in Figure 1 on 
the next page. 
Active glucocorticoids increase the synthesis of glucose and its storage polysaccharide 
form, glycogen.  Because they can bind to the mineralocorticoid receptor, they can act like 
aldosterone and increase the absorption of sodium ions.  Therefore, it is important to have 
sufficient 11-β HSD2 activity in the placentas to protect against high levels of maternal active 
glucocorticoids [Staud, 2006]. If excessive amounts of maternal corticosteroids accumulate in 
the fetal tissues, this can lead to higher risks for hypertension and other diseases in adulthood 
[Struwe, 2007]. 
This study addresses a related problem.  If maternal aldosterone levels are decreased 
through cryodestruction of adrenal glands, will this lower active maternal glucocorticoid levels 
and subsequently affect placental levels of the HSD enzymes?  Which of the two HSD placental 
enzymes are affected and in what way?  If the lowering of maternal aldosterone levels decreases 
hypertension in the mother, is this programmed into the offspring?  What is the role of the HSD 
isoenzymes in these mechanisms?  This study is part of larger study currently being done by Dr. 
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Knoblich and co-workers.  They are studying the hormonal and blood pressure effects of 
lowering maternal aldosterone, and this study is designed to look at the enzymatic effects. 
 
 
Figure 1.  Reactions of the HSD isoenzymes 
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The 11β-HSD1 enzyme catalyzes the largest production of active glucocorticoids from 
inactive 11-keto metabolites and many of these reactions occur in the liver microsomes [Lloyd, 
1999]. It generally uses NADPH to carry out the reduction reaction to produce active 
glucocorticoids ( Figure 1).  However, it is also capable of catalyzing the reverse reaction. The 
molecular weight of the monomer unit is approximately 31.9 kDa. Because this enzyme is a 
glycosylated protein, the masses may vary [Dotsch, 2002].  Limited evidence exists for the active 
dimer forms which are capable of showing positive cooperativity in their kinetic properties 
[Maser, 2002]. 
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The 11 β-HSD1 enzyme is also produced in the rat kidney where there are high amounts 
present.   It is unclear what its role is in human kidney although recent studies support a 
dehydrogenase function [Gong, 2008]. 
The second of the isoenzymes is 11β-HSD2. This enzyme is considered unidirectional as 
a dehydrogenase using the coenzyme NAD+.   It inactivates the glucocorticoids through their 
oxidation (Figure 1).  The molecular weight of the monomer unit is approximately 43.7 kDa. 
There are limited studies which suggest that this isoenzyme may also dimerize because of 
oxidation creating disulfide linkages, but unlike HSD1, it becomes inactive in this dimer form. 
[Gomez-Sanchez, 2001] 
A summary comparing the two isoenzymes is given in Table 1 below: 
 
Table 1. A Comparison of the 11B-HSD Isoenzymes 
 
11Β-HSD 1  11Β-HSD 2  
 31.9 kDa (varies with glycosylation)   43.7 kDa  
 Functions bi-directionally   Functions unidirectionally  
 Can act as a reductase with NADPH 
to produce active glucocorticoids 
  Acts an oxidase with NAD+ to 
produce inactive glucocorticoids 
 
 Can act as an oxidase to 
produce inactive glucocorticoids 
  Allows aldosterone access to 
mineralocorticoid receptor 
 
 Liver and kidney, placenta, others   Kidney and liver, placenta, others  
These two enzymes are important in controlling active glucocorticoid levels. The active 
glucocorticoids can compete with the hormone aldosterone for the mineralcorticoid receptor. 
Either of the two hormones can bind to the mineralcorticoid receptor (MR) leading to the 
transcription and translation of the sodium ion channel protein and the sodium/potassium 
ATPase.  The net effect of this hormonal cascade is to increase sodium reabsorption and to 
increase hypertension [Bocchi, 2003]. HSD2 is known to function in the kidney to inactivate 
cortisol or corticosterone (See Figure 2 below.) and prevent hypertension which could result 
from the glucocorticoids occupying the MR. [Lloyd, 1999]. 
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Figure 2.  Hormonal Mechanisms at the Mineralcorticoid Receptor 
 
 
 
 
 
Placental 11β-HSD2 protects the fetus from the high circulating levels of the maternal 
glucocorticoids.  When the cortisol crosses the placenta of the animal it becomes inactivated and 
doesn’t hurt the growing embryo.  In rodents 11β-HSD2 expression is very high and is related to 
fetal weight at midgestation, but drops dramatically toward the end of the term [Krozowski, 
1999]. Chronic stress in the maternal rats does not allow for increased 11β-HSD2 activity 
although acute stress near term did increase levels of the enzyme to protect the fetus from 
increased levels of maternal corticosterone  [Welberg, 2005]. 
11 β -HSD2 also plays a role in hormonal programming.  When fetal and placental 11 β - 
HSD2 levels are insufficient, this can promote hypertension in adulthood [Fujisawa, 2004].   The 
offspring of rats treated with synthetic glucocorticoid, dexamethasone, during late pregnancy had 
lower birth weights than offspring of control rats and were shown to increase their expression of 
11β -HSD1 [Wan, 2005 ].  The results of these experiments indicated that 11β-HSD1 plays a 
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critical role in the control of normal fetal growth and the subsequent development of adult 
disease. 
In another study, diabetes was drug induced in pregnant normotensive rats and the 
maternal corticosterone levels were reduced [Fujisawa, 2004]. The researchers found that 11β - 
HSD 2 mRNAs decreased significantly in the experimental placentas and fetal kidneys.  Because 
diabetic mothers are known to imprint high blood pressure in their offspring, the authors 
suggested that this may be due in part to the lowered expression of the HSD2 enzyme. 
Other studies suggest that there is a correlation between hypertension in adulthood and 
embryo growth restriction in the human womb.  In their study, Struwe and coworkers [2007] not 
only found that 11β-HSD2 gene expression was reduced in placentae of smaller than normal 
neonates, there was also a corresponding decrease in the expression of 11β-HSD1 gene 
expression.  The authors speculated that this could be a possible mechanism to counteract the 
loss of inactivation of the cortisol hormone because of lowered amounts of HSD2. 
This is  work is part of a larger study by Dr. Knoblich and researchers, who are using 
cryodestruction of the outer layer of the maternal adrenal gland to lower aldosterone levels and 
measure hypertension in the offspring.  Because the programming is known to occur in the fetus 
and because HSD placental enzymes control active glucocorticoid levels, their expressions were 
measured in both normotensive and hypertensive rat placentas.  To accomplish this, the 
feasibility of using a Western blotting technique to semiquantitate HSD isoenzymes from whole 
cell extracts (not microsomes) was examined.  Then, the methods were used to measure the 
expression of the HSD isoenzymes in the placentae of rats with lowered aldosterone levels. 
 
 
. 
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MATERIALS AND METHODS 
 
Treatment of the rats 
 
Four to five week old rats were fasted for 16 hours before surgery. Under anesthesia, 
the right adrenal gland was removed in the experimental rats. The left adrenal gland was frozen 
using a metal spatula dipped in liquid nitrogen, with each area of the gland’s surface frozen three 
times in succession. Control rats underwent a mock or sham surgery with the identical incisions, 
but no removal or freezing procedures were done on the adrenals.   This part of the project was 
conducted by Dr. Knoblich and her students and has IRB approval. 
Isolation of placental tissue 
 
The rats were mated after a recovery period and placentas were removed by Dr. 
 
Knoblich on the 20th day of gestation. They were washed in saline and cut in quarters followed 
by quick freezing in liquid nitrogen.  They were stored in a -80 freezer. 
Isolation of the crude protein extracts 
 
The rat placentas were frozen in liquid nitrogen and then ground to a powder and 
weighed out to give 100 mg of frozen tissue.  The frozen powder was mixed with 4 volumes of 
extraction buffer which consisted of 25mM Tris-HCl, pH 8.0, 200mM Sucrose, 154mM KCl, 
and 20mM DTT.  The protein was then vortexed for 3 minutes with a one minute rest in 
between.  The mixture was then centrifuged for 15 minutes at 10,000 x g.  The crude protein 
extract was then diluted into Laemmli sample buffer to give a final concentration of 300mM 
DTT and 1.3% SDS. Four different concentrations of protein in the range of approximately .5- 
2.5 mg/ml were prepared. The samples were heated for 6 minutes at 100 degree C and 20 ul of 
sample was quantitatively applied to respective wells. 
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Gel Electrophoresis and Blotting 
 
The sample mixtures were run on a 12.5% Laemmli gel (BIO-RAD Criterion), 
equilibrated in 1X Laemmli Buffer, at 35 milliamps for a half hour and then at 40 milliamps for 
two hours and twenty minutes.  The gels were blotted on to polyvinyl-difluoride (PVDF) 
membranes.   The blotting was run in 1X Towbin containing 20% methanol at 85 volts for 75 
minutes. The membranes were taken out and placed in a blocking solution consisting of 4% 
bovine serum albumin (BSA) in a 1X Tris buffered saline, pH 8.0 (TBST) solution containing 
.10 % Tween 20 and then agitated for 60 minutes. The primary antibodies to HSD1 and HSD2 
(Santa Cruz no. 20175 and 20176, respectively ), were put onto the gels at a dilution of 1:1000 
in blocking buffer, and were agitated for 15 minutes and then put into a cold room overnight. 
The following morning they were agitated for one more hour at room temperature. 
 
The gels were then washed in a 1X TBST solution 8 times for 5 minutes each.  The 
secondary antibody (conjugated to peroxidase) was diluted into blocking buffer, at a dilution of 
1:120,000.  The membranes were then agitated for an additional 60 minutes.  The membranes 
were then washed again 8 times for 5 minutes with the 1X TBST. The membranes were then 
soaked in 6.5- 7.0 ml of the SuperSignal West Femto Maximum Sensitivity substrate (Pierce) for 
5 minutes. They were then put onto clear transparency films and sealed with all air bubbles 
being removed. The membranes were then developed using ECL film for 2- 5 seconds. 
Determination of protein concentrations and protein band sizes 
 
The Kaleidoscope protein standards (BIO-RAD) were used to obtain a standard curve for 
molecular weights and to estimate the size of the major protein bands on the blot. 
The Bradford assay (BIO-RAD) was used to determine the ug of protein in each well. 
An average of four samples was taken and BSA was used as the protein for the standard curve. 
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Semi-quantitation of the HSD isoenzymes 
 
The developed film was quantitated using a Hoeffer densitometer and the areas under the 
peaks were determined using Gaussian integration.  The width of the lane was measured and 
used to normalize the sample areas. These areas were then plotted against the ug of protein used. 
Line equations were then used to determine the total area for 50ug of protein and the error 
associated with the number could be estimated from the line fit. 
 
 
RESULTS 
 
I. Optimization of the Blot 
 
The HSD isoenzymes are not abundant proteins.  Most western blots in the literature 
represent the analyses of microsomal extracts.  Because of time and equipment restrictions, this 
project attempted to use whole cell extracts along with a very sensitive chemiluminescent 
substrate to detect these relatively rare enzymes. 
Several blots were run initially to optimize conditions.  The extraction buffer and 
secondary antibody concentrations as well as the blocking protein were varied.  Also, 10% 
polyacrylamide gels were compared to 12.5% gels for the best resolution of protein bands. The 
optimal conditions are given in the materials and methods. Beta actin was initially used for an 
internal standard.  However, because of the multiple bands seen with the other antibodies, it was 
difficult to detect so its use had to be discontinued.   Unfortunately, without the use of an internal 
standard to normalize the areas, it was impossible to compare the numbers among blots. 
None of the conditions gave major bands at the desired molecular weights. Multiple 
bands were seen but the major bands present were a 68kD protein on the HSD1 film and a band 
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representing a 78kD protein on the HSD2 film (Figure 3).   The HSD 2 film also showed a major 
68 kD protein.  This was disturbing since the sequence comparison in the region to which the 
antibody was directed was not highly homologous between the two isoenzymes. However, 
insufficient funds did not allow for the purchase of additional primary antibodies. 
Analysis of adult kidney and liver samples showed multiple bands as well with different 
molecular weights.  Some of the variability can be due to processing and glycosylation 
differences in different tissues.   Because of the literature documentation of dimerization in older 
samples, it was assumed that the dimer forms at 68 kDa and 78 kDa represented HSD 1 and HSD 
2 and since these could be quantitated in all blots, these were the bands which were analyzed. 
 
Figure 3.  Samples Blots of Placental Crude Extracts 
 
 
 
 
II. A comparison of HSD 1 and HSD 2 levels in the treated vs. control WKY samples 
 
A limited number of WKY samples were tested for HSD1 and HSD2 protein expression 
(Table 2).  The results of blot 1 showed no significant differences and those of blot 2 suggest a 
decrease in HSD 1 expression in the experimental placentae. However, one of the experimental 
78kDa- 
68kDa- 
A. Blot using HSD1 primary Ab B. Blot using HSD2 primary Ab 
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Blot 4 DD(15.0) 6732 ± 7269 BB (1.25) 30102 ± 4540 
Blot 2 E (21.6) 
A (10.3) 
average 
5041 ± 2115 I (2.92) 
3491 ±  913 J (19.3) 
4266 ± 1514 average 
1420 ±  86 
1791 ± 187 
1605 ± 136 
Blot 4 DD (15.0) 9588 ± 4428 BB (1.25) 7430 ± 1209 
samples (J) does not show a significantly reduced maternal aldosterone level.   Therefore, the 
very limited preliminary data do not support differences in the expression of the HSD1 enzyme. 
 
 
Table 2. A Comparison of HSD 1 Expression in Control vs. Experimental WKY Placentas 
 
 Control 
WKY Sample 
HSD 1 area Experimental 
WKY Sample 
HSD 1 area 
Blot 1 D (20.9) 
G (10.7) 
average 
19559 ± 7260 
15084 ± 1365 
17321 ± 4312 
B (4.72) 
F  (39.5) 
average 
23967 ± 4868 
18623 ± 1130 
21295 ± 2999 
 
Blot 2 E (21.6) 15678 ± 1390 I (2.92) 6027 ±  370 
 A (10.3) 11931 ± 1550 J (19.3) 8873 ± 2584 
 average 13804 ± 1470 average 7450 ± 1477 
 
 
Numbers in parentheses represent aldosterone levels in ng/dl (Knoblich, personal communication) 
 
 
In blot 1, when HSD2 protein expressions were compared, there were no significant 
differences (Table 3).   In blot 2 there appears to be a decrease in the expression of HSD2 in the 
experimental samples.  However, sample J does not show a reduced maternal aldosterone level. 
Therefore, the limited preliminary data do not support differences in the expression of the HSD2 
enzyme in the placentae of WKY rats with lowered aldosterone levels. 
 
 
Table 3. A Comparison of HSD2 Expression in Control vs. Experimental WKY Placentae 
 
 Control 
WKY Sample 
HSD 2 area Experimental 
WKY Sample 
HSD 2 area 
Blot 1 D (20.9) 
G (10.7) 
average 
12914 ± 8739 
2727 ±  719 
7820 ± 4729 
B (4.70) 
F (39.5) 
average 
5921 ± 836 
4066 ± 160 
4993 ± 498 
 
 
 
 
 
 
Numbers in parentheses represent aldosterone levels in ng/dl  (Knoblich, personal communication) 
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 III.  A comparison of HSD 1 and HSD 2 levels in the treated vs. control SHR samples 
 
The results for the SHR samples (Tables 4 and 5) showed no significant change in the 
protein expression of either isoenzyme.  The error and the inadequate number of experimental 
samples, with reduced maternal aldosterone levels, made it difficult to develop any conclusions. 
 
Table 4.  A Comparison of HSD1 Expression in Control vs. Experimental SHR Placentas. 
 
Control 
SHR Sample 
HSD 1 area Experimental 
SHR Sample 
HSD1 area 
Blot 3 M (13.4) 24740 ± 19548 S (15.2) 9367 ± 1112 
 O (19.5) 11720 ±   3615 N (3.46) 18870 ± 2231 
 average 18230 ± 11581 average 14118 ± 1671 
Blot 4 Q (14.4) 10171 ±   1445 T  (3.35) 14856 ± 3450 
Numbers in parentheses represent aldosterone levels in ng/dl (Knoblich, personal communication) 
 
 
Table 5.  A Comparison of HSD2 Expression in Control vs. Experimental SHR Placentas. 
 
Control 
SHR Sample 
HSD 2 area Experimental 
SHR Sample 
HSD 2 area 
Blot 3 M (13.4) 1596 ±   170 S (15.2) 4341 ± 924 
 O (19.5) 4075 ± 2037 N (3.46) 4753 ± 1521 
 average 2785 ± 1103 average 4547 ± 1222 
Blot 4 Q (14.4) 16100 ± 1506 T (3.35) 15063 ± 2324 
Numbers in parentheses represent aldosterone levels in ng/dl (Knoblich, personal communication) 
 
 
 
DISCUSSION 
 
The limitations of western blotting as a quantitative tool were evident in this project. 
 
When the background was uneven or bubbles occurred in the blot, it made quantitation difficult 
and the error values were high. The use of multiple concentrations helped but limited the 
number of samples which could be analyzed.  The lack of the internal standard made it 
impossible to average sample numbers from one set of blots to the next. Because of variability 
in the rat data, this was a serious limitation in the design and needs to be corrected before further 
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studies are conducted.  Better primary antibodies may solve this problem.  The only affordable 
primary antibodies were polyclonal and gave multiple bands. 
The presence of the dimers has been previously documented in the literature.  It would be 
useful to verify with another source of primary antibody.  It may be that cytosolic forms of the 
enzyme exist in precursor or dimer forms or that aging of the samples causes crosslinks that 
cannot be disrupted by a reducing agent. 
The best approach to measure expression changes may be the measurement of messenger 
RNA (mRNA) levels using reverse transcription and quantitative polymerase chain reaction (RT- 
qPCR).  This technology will soon become available at MSU with the purchase of a real time 
PCR instrument. However, this technique cannot measure changes in expression which occur 
later at the protein level. 
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